Edition:
India

Aerie Pharmaceuticals Inc (AERI.OQ)

AERI.OQ on NASDAQ Stock Exchange Global Market

23.88USD
19 Aug 2019
Change (% chg)

$0.69 (+2.98%)
Prev Close
$23.19
Open
$23.61
Day's High
$24.27
Day's Low
$23.16
Volume
175,105
Avg. Vol
223,868
52-wk High
$64.45
52-wk Low
$20.76

About

Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's product candidates include Rhopressa (netarsudil ophthalmic solution) 0.02%... (more)

Overall

Beta: 1.06
Market Cap(Mil.): $1,913.33
Shares Outstanding(Mil.): 36.34
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates